AVEO Pharmaceuticals, Inc. AVEO
15.00 +15.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 42.30M | 6.02M | 28.80M | 5.41M | 7.58M | |
| 37.56M | 6.02M | 28.80M | 5.41M | 7.58M | |
| -49.55M | -38.88M | -374.00K | -25.36M | -28.81M | |
| -53.34M | -35.58M | 9.39M | -5.33M | -65.03M | |
| -1.63 | -1.66 | 0.61 | -1.93 | -6.14 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 70.54M | 61.76M | 29.79M | 24.43M | 14.95M | |
| 105.34M | 66.91M | 50.60M | 27.93M | 50.20M | |
| 59.47M | 31.62M | 35.75M | 55.16M | 90.96M | |
| 37.97M | 14.48M | 15.77M | 19.03M | 18.48M | |
| 45.87M | 35.29M | 14.85M | -27.23M | -40.76M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| -57.26M | -37.98M | -2.92M | -25.03M | -19.16M | |
| -16.87M | 17.70M | -17.92M | 18.58M | -10.40M | |
| 82.90M | 52.26M | 26.19M | 15.93M | 29.42M | |
| 8.78M | 31.98M | 5.36M | 9.48M | -147.00K |